SOX2 and colorectal cancer: Higher METTL3 expression was observed in metastatic cancerous tissues in colorectal cancer (CRC) patients and is responsible for poor disease prognosis.[36] SOX2 is identified as the downstream target of METTL3, which increases m6A levels in the coding regions of SOX2 mRNA.